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Neuroinflammation	  is	  a	  common	  theme	  in	  a	  spectrum	  of	  central	  nervous	  system	  (CNS)	  diseases	  
resulting	  in	  neuronal	  damage	  and	  degeneration.	  The	  exact	  mechanisms	  regulating	  inflammation	  
in	  the	  CNS	  or	  its	  consequences	  in	  terms	  of	  nerve	  injury	  are	  still	  not	  known	  in	  detail.	  However,	  it	  is	  
known	  that	  many	  inflammatory	  conditions	  at	  least	  in	  part	  are	  regulated	  by	  genetic	  factors.	  Exact	  
definition	  of	   these	   factors	  will	   provide	  a	  better	  understanding	  of	  underlying	  mechanisms.	   The	  
focus	   of	   this	   thesis	   has	   been	   to	   explore	   the	   genetic	   regulation	   of	   neuroinflammation	   in	   viral	  
infections	  and	  mechanical	  nerve	  injuries	  using	  experimental	  models.	  
	  	  
The	  genetic	  regulation	  of	  susceptibility	  to	  Herpes	  simplex	  type-­‐1	  encephalitis	  (HSE),	  a	  devastating	  
condition	  that	  affects	  humans,	  was	  investigated	  in	  different	  inbred	  rat	  strains.	  Using	  a	  series	  of	  
different	  experimental	  approaches	  we	  succeeded	  in	  defining	  two	  different	  candidate	  genes	  that	  
regulate	  susceptibility	  to	  HSE.	  Interestingly,	  these	  genetic	  influences	  act	  at	  two	  different	  stages	  
of	  neurotropic	  HSV-­‐1	  virus	  CNS	  entry.	  Thus,	  the	  calcitonin	  receptor	  (Calcr)	  gene	  was	  identified	  as	  
a	   candidate	   for	   peripheral	   neuronal	   infection	   and	   propagation	   to	   the	   CNS,	   while	   the	   von	  
Willebrand	   factor	   (Vwf)	  gene	  was	   identified	  as	  a	   candidate	   for	  disease	  progression	   in	   the	  CNS	  
and	  blood-­‐brain	  barrier	  (BBB)	  dysfunction.	  The	  latter	  has	  previously	  been	  associated	  to	  cerebral	  
malaria	  infection	  by	  Plasmodium	  falciparum	  and	  endothelial	  cell	  activation,	  suggesting	  that	  this	  
gene	   is	   important	   in	   several	  human	   infectious	  conditions.	  More	  detailed	  histopathological	  and	  
molecular	   studies	   of	   HSV-­‐1	   propagation,	   immune	   cell	   recruitment	   and	   inflammatory	   changes	  
was	  the	  focus	  of	  another	  study,	  which	  provides	  further	  support	  for	  the	  notion	  that	  entry	  of	  virus	  
into	  the	  perineurium	  is	  an	  important	  step	  regulating	  susceptibility	  for	  virus	  propagation	  into	  the	  
CNS.	  Also,	   the	  differences	   found	  between	   the	  studied	  strains	   in	   relation	   to	   immune	  activation	  
and	  responses	  in	  the	  peripheral	  nervous	  system	  (PNS)	  and	  CNS	  clearly	  demonstrate	  that	  genetic	  
factors	   regulate	  virus	   -­‐	  host	   interactions.	  Thus,	  our	   studies	  on	  HSE	  have	  provided	   several	  new	  
perspectives	  of	  how	  susceptibility	  to	  HSV-­‐1	  virus	  can	  be	  regulated	  at	  different	  levels,	  as	  well	  as	  
identifying	  two	  different	  candidate	  genes,	  all	  of	  which	  can	  serve	  as	  basis	   for	   further	  studies	  of	  
human	  HSE.	  	  
	  
In	   a	   fourth	   study,	   the	   genetic	   regulation	   of	   the	   response	   to	   a	   mechanical	   nerve	   injury	   was	  
explored	   in	   order	   to	   identify	   regulatory	   pathways	   for	   innate	   immune	   responses	   occurring	  
without	  an	  infectious	  trigger.	  We	  identified	  two	  quantitative	  trait	  loci	  (QTLs)	  on	  chromosome	  1	  
(Neuinflam4)	  and	  7	  (Neuinflam5),	  respectively,	  regulating	  major	  histocompatibility	  complex	  class	  
II	   (MHC	   II)	   expression	   after	   ventral	   root	   avulsion.	   Additionally,	   another	   QTL	   (Neuinflam9)	   on	  
chromosome	  10	  regulated	  the	  expression	  of	  several	  important	  innate	  immune	  genes,	  including	  
C1q,	  Il1β,	  Tlr2	  and	  Irf7.	  The	  chromosome	  10	  region	  containing	  Neuinflam9	  overlaps	  with	  Toxo1,	  
which	   regulates	   resistance	   to	   Toxoplasma	   gondii	   infection.	   Interestingly,	   a	   part	   of	   this	   QTL	  
conferred	  resistance	  to	  experimental	  autoimmune	  encephalomyelitis	  (EAE),	  an	  animal	  model	  for	  
multiple	   sclerosis	   (MS)	   indicating	   that	   this	  QTL	   could	   regulate	   susceptibility	   both	   to	   infectious	  
and	  autoimmune	  conditions.	  	  	  
	  
In	   conclusion,	   the	   identification	   of	   several	   genetically	   regulated	   pathways	   presented	   herein	  
provides	   a	   basis	   for	   further	   molecular	   exploration	   of	   different	   conditions	   characterized	   by	  
neuroinflammation.	   This	  will	   be	   a	   necessary	   prerequisite	   for	   the	   formulation	   of	   new	   targeted	  
therapeutic	  interventions	  that	  can	  prevent	  permanent	  damage	  to	  the	  nervous	  system.	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